Global Cancer Immunotherapy Market 2018-2025 Analysis By Treatment Studies With Key Competitors Pfizer, AstraZeneca, Bristol Mayers Squibb, IGNITE Immunotherapy, Western Oncolytics Ltd, Targovax, Therapeutics Inc., NewLink Genetics, Ziopharm Oncology
The Global Cancer Immunotherapy Market is expected to reach USD 202.89 Billion by 2025, from USD 70.63 billion in 2017 growing at a CAGR of 14.1% during the forecast period of 2018 to 2025. In September 2017 Merck receives the FDA accelerated approval for pembrolizumab for the treatment of advanced gastric cancer Biothera Pharmaceuticals announces the clinical trial collaboration with Genentech part of F.Hoffman La. Roche Ltd. The global cancer immunotherapy market size was valued at USD 40.7 billion in 2016.
Download PDF sample copy of this research report@ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-immunotherapy-market
The global Cancer immunotherapy Market evokes the immune response against the cancerous cells. Immunotherapy acts by targeting CTLA-4 and PD-1/PD-L1 Pathway. It works either by slowing down the growth of cancer cells or boosts the immune system to destroy the cancerous cells or either it stops the cancer from spreading to other parts of the body. This global Cancer immunotherapy Market report defines the market trends and forecast the upcoming opportunities and threats of the cancer immunotherapy market in the next 8 years.
Major competitors/ Company Profiles
Some of the major players operating in the Global Cancer Immunotherapy Market are-
Hoffmann-La Roche LTd,
Bristol Mayers Squibb,
Johnson and Johnson,
bluebird bio Inc,
Westeren oncolytics ltd,
Oncolys BioPharma Inc,
Cold genesys Inc,
Sorrento Therapeutics Inc,
New-link genetics Corporation,
Tessa therapeutics Pte Ltd,
Orca Therapeutics B.V,
Daiichi Sankyo Co Ltd,
Ascend laboratories LLC,
In 2011, Amgen Inc acquired biovex with USD 1 Billion which was into the oncolytic virus immunotherapy development.
In October 2016, Genetech subsidiary of Roche received the approval for atezolizumab for the treatment of non-small cell lung cancer.
In March 2017, Serono Inc received the FDA accelerated approval for avelumab for the treatment of metastatic merkell cell carcinoma.
To Avail 10% Discount On This Report Mail Us on:- firstname.lastname@example.org
Table of Contents:
• 1. Introduction
• 2. Market Segmentation
• 3. Market Overview
• 4. Executive Summary
• 5. Premium Insights
• 6. Global, By Component
• 7. Product/Service Type
• 8. Delivery
• 9. Industry Type
• 10. Geography
• 10.1. Overview
• 10.2. North America
• 10.3. Europe
• 10.4. Asia-Pacific
• 10.5. South America
• 10.6. Middle East & Africa
• 11. Company Landscape
• 12. Company Profiles
• 13. Related Reports
Major Market Drivers and Restraints:
New technologies and combination product availability is expected to drive the market in the forecast period.
Production of biosimilars and biobetters.
Rising cancer suffering population.
Increased investment in research and development of cancer immunotherapy.
Downward pricing pressure owing to its commodity nature.
The Global Cancer Immunotherapy Market Is Segmented-
By Product Type
By Cancer Type
Head And Neck Cancer
By End Users
Based On Geography, The Global Cancer Immunotherapy Market Report Covers Data Points For 28 Countries Across Multiple Geographies Namely North America & South America, Europe, Asia-Pacific And, Middle East & Africa. Some Of The Major Countries Covered In This Report Are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa And, Brazil Among Others.
Reason to buy the Report:
It helps to know that the Global Cancer Immunotherapy Market product sections along with their future forecast.
It aids for making informed business decisions by utilizing a comprehensive analysis of market sections and from having whole insights of Cancer Immunotherapy Market.
It poses a forward-looking prospect on distinct facets controlling and Global Cancer Immunotherapy Market
This poses a six-year Global Cancer Immunotherapy Market forecast assessment primarily based mostly on the way the sectors are anticipated.
Global Cancer Immunotherapy market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
All segmentation provided above in this report is represented at country level and can be customized according to needs.
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization).
Inquire Regarding This Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cancer-immunotherapy-market
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cancer Immunotherapy Market 2018-2025 Analysis By Treatment Studies With Key Competitors Pfizer, AstraZeneca, Bristol Mayers Squibb, IGNITE Immunotherapy, Western Oncolytics Ltd, Targovax, Therapeutics Inc., NewLink Genetics, Ziopharm Oncology here
News-ID: 1230952 • Views: 352
More Releases from Data Bridge Market Research
Radiotherapy Market is Booming Worldwide With CIVCO Medical Solutions, Brainlab …
Global Radiotherapy Market is expected to reach at a CAGR of 7.7% in the forecast period of 2018 to 2025. Global Radiotherapy Market, By Therapy (Beam Radiotherapy, Brachytherapy, Systemic Radiotherapy), By Product Type (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Softwares, Systemic Radiotherapy), By Application (Prostrate Cancer, Breast Cancer, Lung Cancer, Spine Cancer, Liver Cancer, Brain Cancer, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) –
Cable Assembly Market Quantitative Analysis By TE Connectivity, Molex, LLC, W. L …
The cable assembly report aids in achieving an extreme sense of evolving industry movements before the competitors. This market research report gives clear idea about strategic analysis of mergers, expansions, acquisitions, partnerships, and investment. It becomes easy to analyse the actions of key players and its effect on the sales, import, export, revenue and CAGR values with this cable assembly report. The report is also a helpful source of assistance
Aroma Chemicals Market 2019:Quantitative Analysis By Hindustan Mint & Agro Produ …
The market analysis of aroma chemicals market report provides an examination of various market segments that are supposed to witness the fastest development amid the estimated forecast frame. A comprehensive market research has been conducted in this report which puts a light on the challenges, market structures, opportunities, driving forces, scope, and competitive landscape for your business. The best tools have been adopted to generate this report which is SWOT
Industrial Communication Market 2019:Industry Analysis By OMRON Corporation, Sch …
Global industrial communication market is set to witness a healthy CAGR of 11.12% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing adoption of industrial internet of things and increasing demand for wireless networks are the factor for the growth of this market. Industrial communication report is a well-generated market report which helps achieve comprehensive analysis of the market
More Releases for Cancer
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and